- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
DR enhancement minimizes patient movement
A new option for the Kodak DirectView DR 9000 digital radiography system may accelerate treatment and improve care at trauma centers by minimizing the movement of critically injured patients. The transbay option involves installing overhead rails up to
A new option for the Kodak DirectView DR 9000 digital radiography system may accelerate treatment and improve care at trauma centers by minimizing the movement of critically injured patients. The transbay option involves installing overhead rails up to 30 feet long. The rails allow the Kodak DR system to move to as many as three different patient locations in rapid succession. Installation can be customized to meet the unique needs of individual hospital trauma centers. The company claims that a movable DR 9000 system, supported by other specialized equipment, allows the assessment and stabilization of patients in 15 minutes instead of the typical 45 minutes. In addition to the potential patient benefits of initiating treatment earlier, the ability to rapidly assess multiple trauma patients promises substantial cost savings and enhanced productivity, according to Kodak.
Four Strategies to Address the Tipping Point in Radiology
January 17th 2025In order to flip the script on the impact of the radiology workforce shortage, radiology groups and practices need to make sound investments in technologies and leverage partnerships to mitigate gaps in coverage and maximize workflow efficiencies.
Can Generative AI Facilitate Simulated Contrast Enhancement for Prostate MRI?
January 14th 2025Deep learning synthesis of contrast-enhanced MRI from non-contrast prostate MRI sequences provided an average multiscale structural similarity index of 70 percent with actual contrast-enhanced prostate MRI in external validation testing from newly published research.
Can MRI-Based AI Enhance Risk Stratification in Prostate Cancer?
January 13th 2025Employing baseline MRI and clinical data, an emerging deep learning model was 32 percent more likely to predict the progression of low-risk prostate cancer (PCa) to clinically significant prostate cancer (csPCa), according to new research.
